358 filings
Page 4 of 18
8-K
8ski2jehx0
10 Mar 22
Viridian Therapeutics Reports Fourth Quarter and Full Year 2021
4:16pm
EFFECT
lgjv uprdi0
18 Nov 21
Notice of effectiveness
12:15am
CORRESP
aqk3iar1q 0s
15 Nov 21
Correspondence with SEC
12:00am
UPLOAD
m7mka18sg
10 Nov 21
Letter from SEC
12:00am
8-K
8tlpe1xxwqa
8 Nov 21
Other Events
9:08am
8-K
b7kfge705 zyzn8l
4 Nov 21
Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
4:17pm
8-K
7qn34ai8qr3
23 Sep 21
Entry into a Material Definitive Agreement
4:30pm
424B5
8yss9z7
22 Sep 21
Prospectus supplement for primary offering
5:20pm
424B5
8wt7 omu2xeu
20 Sep 21
Prospectus supplement for primary offering
4:12pm
8-K
xbu zdatwa754
11 Aug 21
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
7:17am
8-K
7wkj62o
26 Jul 21
Viridian Therapeutics Appoints Kristian Humer As Chief
7:35am
8-K
s23r6 96avzqwez
15 Jul 21
Viridian Therapeutics Appoints Jennifer Moses, Cpa to the Board of Directors and As Chair of the Audit Committee
4:13pm
8-K/A
4yofq 9g8mkic8ikw
15 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:30pm
DEFA14A
ogiq6a0 ryrfly8akqq
4 Jun 21
Additional proxy soliciting materials
6:13am
8-K
o0153fndpq5f1fk
4 Jun 21
Departure of Directors or Certain Officers
6:08am
8-K
k5vh frsmicu
17 May 21
Departure of Directors or Certain Officers
4:04pm